129770966740937500_116Report from (reporter Li Hongpeng Wang Tingting interns) Bulletin of the State food and drug administration released 23rd, reminded medical personnel and concerns of xiangdan injection in patients with severe adverse reactions such as anaphylactic shock
tera power leveling, breathing difficulties. Xiangdan injection in the main components of Lignum Dalbergia odoriferae, Radix salviae miltiorrhizae and its indications of dilated blood vessels, increase coronary blood flow. For clinical useIn angina, also can be used, such as myocardial infarction. According to statistics, in 2011, the national monitoring centre for adverse drug reaction case reports about 2,413 xiangdan injection in case reports in the database, in which case report of 180 cases of serious adverse reaction. Most of the severe adverse drug reactions occur in the first days of drug use, mainly for an allergic-like reaction, anaphylactic shock, respiratory difficultiesDifficult
tera power leveling, and so on. State food and Drug Administration recommends that medication should be carefully before asking medical staff patients with allergies, drug allergies are disabled.
Medication monitoring should be strengthened, unusual, stop immediately
tera gold, proactive treatment where patients. Zhuifang reporter search for production of xiangdan injection enterprises today, found as many as dozens of homes, including shenwei medicine industry, Ltd, Yunnan baiyao group sharesLimited drug and other famous enterprises. This morning, shenwei medicine industry limited company technology Senior Director Liu Tiejun said the company in the drug package insert was revised on November 10 last year, taboo up to 4 drugs, doctors note the use of up to 13, the doctor provides a basis for rational use of medicines. "Taboo and the drugs have less attention than it is nowSeveral. "Liu Tiejun said. (Editors: Song Yuxin)
Others:
没有评论:
发表评论